173 related articles for article (PubMed ID: 36418670)
1. Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning.
Li J; Mi L; Ran B; Sui C; Zhou L; Li F; Dionigi G; Sun H; Liang N
J Endocrinol Invest; 2023 Jun; 46(6):1131-1143. PubMed ID: 36418670
[TBL] [Abstract][Full Text] [Related]
2. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.
Zhan S; Li J; Wang T; Ge W
Oncologist; 2018 Dec; 23(12):1415-1425. PubMed ID: 29739896
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of tissue proteomics in patients with papillary thyroid microcarcinoma uncovers the underlying mechanism of lymph node metastasis and its significant sex disparities.
Cao Z; Zhang Z; Tang X; Liu R; Wu M; Wu J; Liu Z
Front Oncol; 2022; 12():887977. PubMed ID: 36106120
[TBL] [Abstract][Full Text] [Related]
5. Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma.
Zhang H; Zheng X; Liu J; Gao M; Qian B
Front Endocrinol (Lausanne); 2022; 13():896121. PubMed ID: 35937812
[TBL] [Abstract][Full Text] [Related]
6. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
Ruiz EML; Niu T; Zerfaoui M; Kunnimalaiyaan M; Friedlander PL; Abdel-Mageed AB; Kandil E
Surgery; 2020 Jan; 167(1):73-79. PubMed ID: 31711617
[TBL] [Abstract][Full Text] [Related]
7. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties.
Lee S; Bae JS; Jung CK; Chung WY
Cancer Med; 2019 Nov; 8(15):6528-6537. PubMed ID: 31498560
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of the papillary thyroid microcarcinoma.
Jin S; Bao W; Yang YT; Fu Q; Bai Y; Liu Y
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):293-300. PubMed ID: 31606199
[TBL] [Abstract][Full Text] [Related]
9. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.
Ye J; Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Shi WH; Jiang Y
Front Endocrinol (Lausanne); 2021; 12():770824. PubMed ID: 35095755
[TBL] [Abstract][Full Text] [Related]
10. In-Depth Proteomics Analysis to Identify Biomarkers of Papillary Thyroid Cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.
Zhan S; Wang T; Wang M; Li J; Ge W
Proteomics Clin Appl; 2019 Sep; 13(5):e1900030. PubMed ID: 31148369
[TBL] [Abstract][Full Text] [Related]
11. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas.
Wang Y; Cheng T; Lu M; Mu Y; Li B; Li X; Zhan X
EPMA J; 2019 Dec; 10(4):395-414. PubMed ID: 31832114
[TBL] [Abstract][Full Text] [Related]
12. TMT-labeling Proteomics of Papillary Thyroid Carcinoma Reveal Invasive Biomarkers.
Dai J; Yu X; Han Y; Chai L; Liao Y; Zhong P; Xie R; Sun X; Huang Q; Wang J; Yin Z; Zhang Y; Lv Z; Jia C
J Cancer; 2020; 11(20):6122-6132. PubMed ID: 32922552
[No Abstract] [Full Text] [Related]
13. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Sun J; Jiang Q; Wang X; Liu W; Wang X
Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes associated with papillary thyroid microcarcinoma characteristics by integrating transcriptome sequencing and weighted gene co-expression network analysis.
Yang F; Lian M; Ma H; Feng L; Shen X; Chen J; Fang J
Gene; 2022 Feb; 811():146086. PubMed ID: 34856364
[TBL] [Abstract][Full Text] [Related]
15. In search of new stratification strategies: tissue proteomic profiling of papillary thyroid microcarcinoma in patients with localized disease and lateral neck metastases.
Matovinovic F; Novak R; Hrkac S; Salai G; Mocibob M; Pranjic M; Košec A; Bedekovic V; Grgurevic L
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17405-17417. PubMed ID: 37861757
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic analysis of gingival crevicular fluids to identify novel biomarkers of gingival recession in orthodontic patients.
Pei F; Wang M; Wang Y; Pan X; Cen X; Huang X; Jin Y; Zhao Z
J Proteomics; 2022 Aug; 266():104647. PubMed ID: 35779762
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.
Wei X; Min Y; Feng Y; He D; Zeng X; Huang Y; Fan S; Chen H; Chen J; Xiang K; Luo H; Yin G; Hu D
J Endocrinol Invest; 2022 Mar; 45(3):507-515. PubMed ID: 34491546
[TBL] [Abstract][Full Text] [Related]
18. Proteomics analysis indicates the involvement of immunity and inflammation in the onset stage of SOD1-G93A mouse model of ALS.
Chen L; Wang N; Zhang Y; Li D; He C; Li Z; Zhang J; Guo Y
J Proteomics; 2023 Feb; 272():104776. PubMed ID: 36423857
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
20. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
